Coloplast
Coloplast is a global medical device company serving patients with ostomy, continence, wound, and urological needs through proprietary devices (SenSura Mio, SpeediCath, Titan, Restorelle) and NHS-integrated nursing, telehealth, and home delivery services.
- Company typePublic
- Founded1954
- HeadquartersPeterborough, United Kingdom
- Headcount1–10
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Coloplast does
Coloplast is a global medical device company founded in 1954 in Denmark and headquartered in Humlebæk, with UK operations conducted through Coloplast Limited (Peterborough). The group operates four interconnected business areas: Ostomy Care, Continence Care, Wound & Skin Care, and Interventional Urology, serving patients with stomas, bladder/bowel dysfunction, chronic wounds, erectile dysfunction, stress urinary incontinence, and pelvic organ prolapse. Its technology stack is built on proprietary materials and devices including the SenSura Mio ostomy portfolio with BodyCheck adaptive fit, the SpeediCath and Luja families of hydrophilic-coated intermittent catheters, the Titan/Titan Touch inflatable penile prostheses (using Bioflex cylinders), the Virtue male sling, the Restorelle ultra-lightweight polypropylene mesh, and the Biatain/Comfeel wound dressing ranges.
Coloplast generates revenue predominantly through hardware sales of medical devices, distributed through a hybrid GTM model. In the UK, the company sells directly to NHS trusts and integrated care boards via centralised prescribing solutions and APMS procurement frameworks, runs a CQC-regulated nursing and telehealth service supporting ~41,500 UK patients per year, and operates the Coloplast Charter home delivery service for direct-to-consumer prescription fulfillment. The Coloplast ProAct digital prescription platform integrates with NHS systems such as EMIS. The company has ~11,000 employees globally, maintains 32 country websites, and reports product and care-area metrics that support 70,000+ patient-years of UK prescription experience. Coloplast A/S is publicly listed on the Copenhagen Stock Exchange (ticker COLO.B); the UK entity is a wholly-owned private subsidiary.
Coloplast firmographics
Firmographics- Name
- Coloplast
- Legal name
- Coloplast Limited
- Website
- https://coloplast.co.uk
- Company type
- Public
- Founded year
- 1954
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Coloplast is a global medical device company serving patients with ostomy, continence, wound, and urological needs through proprietary devices (SenSura Mio, SpeediCath, Titan, Restorelle) and NHS-integrated nursing, telehealth, and home delivery services.
- Ownership category
- akta.pro rank
Coloplast industry classification
Industry- Product category
- Intimate Healthcare Medical Devices
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113), Health Care and Social Assistance (62)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Ostomy Care Products (Pouches, Barriers/Wafers, Accessories, Skin Protection) (HLAHALAG)
- akta.pro secondary industries
- Continence Care Products (Adult Incontinence Pads/Briefs, Underpads, External Collectors) (HLAHALAH), Single-Use Medical Disposables & Procedure Kits (Drapes, Tubing, Catheters, Syringes, Custom Packs) (HLAHANAG), Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits) (HLAHADAM), Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools) (HLAHADAN), Incontinence & Urological Supplies (Catheters, Briefs, Ostomy Supplies) (HSABAKAH)
Keywords
Where Coloplast is headquartered
LocationHeadquarters
- HQ city
- Peterborough
- HQ country
- United Kingdom
- HQ region
- Europe
Offices2 records
Markets served
Coloplast business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Medical Device Product Sales: Coloplast generates revenue through the sale of medical devices and healthcare products across four business areas: Ostomy Care, Continence Care, Wound & Skin Care, and Urology Care. Products are sold to healthcare providers, the NHS, and directly to patients through the Coloplast Charter home delivery service.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels6 records
Coloplast product offering
Product offeringCore offering
Coloplast develops, manufactures, and distributes medical devices and supporting services across four business areas: Ostomy Care (adhesive stoma pouches and accessories such as SenSura Mio and Brava), Continence Care (hydrophilic catheters, urinary sheaths, and bowel irrigation systems such as SpeediCath, Luja, Conveen, and Peristeen), Wound & Skin Care (Biatain and Comfeel dressings), and Interventional Urology (Titan and Genesis penile implants, Virtue male slings, Restorelle pelvic mesh, and bladder injection needles). Products are sold to NHS trusts and healthcare providers and delivered directly to patients through the Coloplast Charter home delivery service.
Product overview
Coloplast is a global medical device company offering an integrated portfolio of intimate healthcare products and services across four core business areas: Ostomy Care, Continence Care, Wound & Skin Care, and Interventional Urology. The product ecosystem centers on SenSura Mio ostomy pouches and Brava accessories for stoma care; SpeediCath and Luja catheters, Conveen sheaths for continence management; Biatain and Comfeel wound dressings; and Titan/Titan Touch and Genesis penile implants, Virtue male slings, Restorelle pelvic mesh, and various sling systems for urological procedures. Services include Coloplast Charter (home delivery), Nursing and Telehealth Service, and Coloplast ProAct digital prescription management. Tools include Male Catheter Finder, Ostomy Self-assessment Tools, and WheelMate app.
Differentiator
Problem solved
Functional benefit
Brands
- SenSura Mio: Ostomy portfolio offering innovative pouches for users with stomas
- SpeediCath
- Conveen
- Brava
- Titan
- Genesis
- Restorelle
- Peristeen
- Luja
- Coloplast ProAct
- WheelMate
- Heylo
Products and services
- SenSura Mio Innovative ostomy pouch range with adhesive technology that adapts to body changes and helps prevent leakage. Available in multiple colors including a Black edition. Designed for people living with a stoma following ostomy surgery.
- Brava Protective Seal Protective seal accessory for ostomy patients that provides confidence and helps prevent leakage around the stoma.
- Heylo Stoma leak detection device that monitors and alerts users to potential leakage issues before they become problematic. Designed for ostomy patients seeking confidence in daily activities.
- SpeediCath Range of instantly ready-to-use hydrophilic-coated catheters for intermittent catheterisation, available in male, female, compact, and flexible designs for patients managing bladder dysfunction.
- SpeediCath Flex Flexible hydrophilic catheter with bag integration for discreet catheterisation, designed for ease of use and hygienic handling for intermittent self-catheterisation users.
- SpeediCath Compact Eve Compact female catheter with triangular grip, pre-lubricated and sized like mascara for discreet portability, designed for women performing intermittent self-catheterisation.
- Luja Next-generation male and female catheter designed to reduce the risk of urinary tract infections (UTIs) with advanced tip technology, representing the next generation of catheter design.
- Conveen Optima Urinary sheath system for male incontinence consisting of a sheath worn on the penis connected to a urine collection bag, offering discreet all-day protection. Available in 5 different sizes and 2 lengths, worn for up to 24 hours.
- Peristeen Light 250ml with Extension Tube Bowel irrigation system for transanal irrigation, helping manage bowel dysfunction. Now available in 250ml size with extension tube.
- Biatain Silicone Soft silicone wound dressing for infected and non-infected wounds, designed for superior absorption and gentle adhesion in patients requiring wound care.
- Biatain Fiber Fiber-based wound dressing technology for advanced wound management in patients with complex wounds.
- Biatain Silicone Ag Silver-containing silicone wound dressing for infected wounds providing antimicrobial protection.
- Comfeel Plus Hydrocolloid wound dressing for moderate to heavily exuding wounds.
- Titan Touch Advanced three-piece inflatable penile prosthesis with improved pump technology requiring 22% less force to activate, Bioflex cylinders, and lock-out valve for preventing auto-inflation. Used for surgical treatment of erectile dysfunction.
- Titan Self-contained fluid-filled inflatable penile prosthesis consisting of reservoir, penile cylinders, and pump connected by silicone tubing. Available in standard and narrow sizes with MRI conditional and latex-free properties. Used for surgical treatment of erectile dysfunction.
- Genesis Malleable penile prosthesis with hydrophilic coating for surgical placement ease. Features no springs, cables, or moving parts with trimmable design for custom sizing. Used for surgical treatment of erectile dysfunction.
- Virtue Male Sling Minimally invasive quadratic-designed sling for treatment of mild to severe stress urinary incontinence in male patients. Features four-arm approach with 100% monofilament polypropylene mesh.
- Restorelle Ultra-lightweight polypropylene mesh for pelvic organ prolapse repair. Physiologically compatible design encourages collagen growth for optimal surgical outcomes.
- Aris Sling Transobturator and suprapubic sling systems for female stress urinary incontinence treatment, among the lightest slings on the market with low elasticity.
- Altis Single incision sling for female stress urinary incontinence using the same proven material as Aris with fixation-less design.
- BoNee Dedicated bladder injection needle for delivering low viscosity medications precisely into the bladder wall during transurethral endoscopic procedures. Features 4mm tip, 22 gauge, available in 35cm and 70cm lengths.
- Hydro X-Flow Prostatic Catheter Hydrophilic-coated prostatic catheter with Dufour, Delinotte, and Couvelaire tip options for improved insertion and withdrawal during prostate procedures.
- Folysil All silicone Foley in-dwelling catheter for bladder drainage with up to 12-week indwelling time.
- Coloplast Charter UK home delivery service for stoma, continence, and bowel products with easy online ordering, reliable delivery, and access to product specialists and nursing support. Listed on major NHS APMS frameworks.
- Nursing and Telehealth Service CQC-regulated nursing and telehealth service partnering with the NHS to support individuals with intimate healthcare needs, providing specialist care from Registered Nurses and product delivery.
- Coloplast ProAct Digital prescription management system for NHS organisations enabling seamless integration with NHS systems like EMIS for prescription processing and compliance management.
Quantifiable outcome
- CQC 'Outstanding' inspection rating achieved in 2021 for Coloplast UK's nursing and telehealth service — the only company in the field to receive this rating in England
- +4 more outcomes
Companies that use Coloplast
Customer profileNamed customers8 records
Segments5 records
Ideal customer profiles5 records
Coloplast technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature10 records
Coloplast partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and minor.
- NHS (National Health Service)coreColoplast has partnered with the NHS for over 60 years delivering centralised prescribing solutions that improve patient care and reduce system pressures. Partnerships include NHS trusts, integrated care boards (e.g., Sefton ICB), and NHS procurement frameworks such as the East of England NHS Collaborative Procurement Hub and Countess of Chester NHS Foundation Trust. The partnership provides prescription management services, clinical nurse specialist reviews, and CQC-regulated nursing and telehealth support for over 18,500 patients.
- Healthcare CharitiesminorColoplast's nursing and telehealth service partners with charities to support individuals with intimate healthcare needs, including those living with a stoma or requiring intermittent self-catheterisation.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
Coloplast competitors and assessment
Company assessmentDirect peers
- Hollister Incorporated: Hollister is a privately held US medical device company that directly competes with Coloplast in ostomy care (Hollister ostomy pouches, Adapt accessories) and continence care (VaPro catheters). It shares Coloplast's patient-direct distribution philosophy and competes for NHS ostomy framework contracts in the UK.
- B. Braun: B. Braun is a major European medical device manufacturer with a direct overlap in continence care (Actreen intermittent catheters, Urimed) and wound care (Askina dressings). It competes with Coloplast for NHS catheter and wound dressing contracts and shares the multi-specialty, European-anchored profile.
- Salts Healthcare: Salts Healthcare is a UK-based ostomy and continence manufacturer with a strong NHS heritage that directly competes with Coloplast in stoma care products, adhesives, and accessories. As a smaller UK specialist, it competes with Coloplast on NHS prescription frameworks and home delivery services.
- ConvaTec: ConvaTec is the most direct global competitor to Coloplast, operating across the same three franchises — ostomy care, advanced wound care, and continence care — with comparable NHS and hospital distribution. Its ostomy (Esteem, Natura) and continence (GentleCath) portfolios directly contest Coloplast's SenSura Mio and SpeediCath lines, and both companies compete for NHS framework listings in the UK.
- Wellspect Healthcare: Wellspect (a former Astra Tech business, now owned by Mölnlycke) directly competes in hydrophilic intermittent catheterization with LoFric — one of SpeediCath's main global rivals — and also in transanal irrigation (Navina), overlapping with Coloplast's Peristeen portfolio. It is a direct niche competitor in UK continence care.
Broad incumbents
- Boston Scientific: Boston Scientific is a major global urology and pelvic health device company, directly competing with Coloplast's interventional urology franchise (penile implants, male slings, pelvic mesh). Its AMS penile implant line and women's health portfolio overlap with Titan, Virtue, and Restorelle, while its broader portfolio extends well beyond Coloplast's niche.
- Smith+Nephew: Smith+Nephew is a large diversified medical device company with a meaningful advanced wound care portfolio (Allevyn, PICO single-use negative pressure wound therapy) that directly competes with Coloplast's Biatain range. It is a broader incumbent focused on multiple surgical and wound segments rather than intimate healthcare.
- Mölnlycke Health Care: Mölnlycke is a global wound care leader (Mepilex, Mepitel) that directly competes with Coloplast's Biatain portfolio in advanced wound dressings. Through its ownership of Wellspect it also overlaps in continence, positioning it as a broader incumbent across Coloplast's two adjacent franchises.
- Cook Medical: Cook Medical is a broad interventional medical device manufacturer with overlapping product categories in urology (Foley catheters, stone management, BPH devices) and pelvic health. Its hydrophilic-coated Foley catheters compete with Coloplast's Folysil and Hydro X-Flow products in hospital channels.
- Medline Industries: Medline is one of the largest privately held medical supply manufacturers and distributors, offering a broad portfolio that overlaps with Coloplast in continence (catheters), wound care (dressings), and ostomy accessories. It is a broader incumbent competing across hospital and homecare distribution channels.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Coloplast social profiles
Digital presenceColoplast compliance and trust
Trust signalCompliance4 records
Coloplast financial estimates
Financial estimateRevenue estimate
Valuation estimate
Coloplast leadership team
Management profileNumber of profiles
Coloplast subsidiaries and ownership
Company hierarchySubsidiaries1 record
Coloplast funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Coloplast M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Coloplast
What does Coloplast do?
Coloplast develops, manufactures, and distributes medical devices and supporting services across four business areas: Ostomy Care (adhesive stoma pouches and accessories such as SenSura Mio and Brava), Continence Care (hydrophilic catheters, urinary sheaths, and bowel irrigation systems such as SpeediCath, Luja, Conveen, and Peristeen), Wound & Skin Care (Biatain and Comfeel dressings), and Interventional Urology (Titan and Genesis penile implants, Virtue male slings, Restorelle pelvic mesh, and bladder injection needles). Products are sold to NHS trusts and healthcare providers and delivered directly to patients through the Coloplast Charter home delivery service.
Is Coloplast a public or private company?
Coloplast is a public company. It is classified as public and is currently operating.
When was Coloplast founded?
Coloplast was founded in 1954. It employs 1 to 10 people.
Where is Coloplast based?
Coloplast is headquartered in Peterborough, United Kingdom, in the Europe region.
How does Coloplast make money?
One revenue line is on record: medical Device Product Sales.
Who are Coloplast's main competitors?
Direct peers on record are Hollister Incorporated, B. Braun, Salts Healthcare, ConvaTec and Wellspect Healthcare. Broad incumbents are Boston Scientific, Smith+Nephew, Mölnlycke Health Care, Cook Medical and Medline Industries.
Does Coloplast have an API?
No public API is recorded for Coloplast.
What industry is Coloplast in?
Coloplast's product category is Intimate Healthcare Medical Devices. Its primary akta.pro industry code is HLAHALAG, Ostomy Care Products (Pouches, Barriers/Wafers, Accessories, Skin Protection), with a secondary code of HLAHALAH, Continence Care Products (Adult Incontinence Pads/Briefs, Underpads, External Collectors). Its NAICS code is 339113 and its SIC code is 3841.